Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288–300. https://doi.org/10.21037/tlcr.2016.06.07.
Article CAS PubMed PubMed Central Google Scholar
Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H, Hizawa N. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mole Clin Oncol. 2015;3(1):217–21. https://doi.org/10.3892/mco.2014.410.
Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781–3. https://doi.org/10.1101/gad.1787609.
Article CAS PubMed PubMed Central Google Scholar
Cheng T, Zhan X. Pattern recognition for predictive, preventive, and personalized medicine in cancer. EPMA J. 2017;8(1):51–60. https://doi.org/10.1007/s13167-017-0083-9.
Article CAS PubMed PubMed Central Google Scholar
Lu M, Zhan X. The crucial role of multiomic approach in cancer research and clinically relevant outcomes. EPMA J. 2018;9(1):77–102. https://doi.org/10.1007/s13167-018-0128-8.
Article PubMed PubMed Central Google Scholar
Golubnitschaja O, Costigliola V. EPMA General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive Preventive Personalised Medicine. EPMA J. 2012;3(1):14. https://doi.org/10.1186/1878-5085-3-14.
Article PubMed PubMed Central Google Scholar
Golubnitschaja O, Filep N, Yeghiazaryan K, Blom HJ, Hofmann-Apitius M, Kuhn W. Multi-omic approach decodes paradoxes of the triple-negative breast cancer: lessons for predictive, preventive and personalised medicine. Amino Acids. 2018;50(3–4):383–95. https://doi.org/10.1007/s00726-017-2524-0.
Article CAS PubMed Google Scholar
Greenberg MVC. Bourc’his D, The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590–607. https://doi.org/10.1038/s41580-019-0159-6.
Article CAS PubMed Google Scholar
Koziol MJ, Bradshaw CR, Allen GE, Costa ASH, Frezza C, Gurdon JB. Identification of methylated deoxyadenosines in vertebrates reveals diversity in DNA modifications. Nat Struct Mol Biol. 2016;23(1):24–30. https://doi.org/10.1038/nsmb.3145.
Article CAS PubMed Google Scholar
Liu J, Zhu Y, Luo GZ, Wang X, Yue Y, Wang X, Zong X, Chen K, Yin H, Fu Y, et al. Abundant DNA 6mA methylation during early embryogenesis of zebrafish and pig. Nat Commun. 2016;7:13052. https://doi.org/10.1038/ncomms13052.
Article CAS PubMed PubMed Central Google Scholar
Wu TP, Wang T, Seetin MG, Lai Y, Zhu S, Lin K, Liu Y, Byrum SD, Mackintosh SG, Zhong M, et al. DNA methylation on N(6)-adenine in mammalian embryonic stem cells. Nature. 2016;532(7599):329–33. https://doi.org/10.1038/nature17640.
Article CAS PubMed PubMed Central Google Scholar
Hao Z, Wu T, Cui X, Zhu P, Tan C, Dou X, Hsu KW, Lin YT, Peng PH, Zhang LS, et al. N(6)-Deoxyadenosine methylation in mammalian mitochondrial DNA. Mol Cell. 2020;78(3):382-395.e388. https://doi.org/10.1016/j.molcel.2020.02.018.
Article CAS PubMed PubMed Central Google Scholar
Musheev MU. Baumgne, The origin of genomic N(6)-methyl-deoxyadenosine in mammalian cells. Nat Chem Biol. 2020;16(6):630–4. https://doi.org/10.1038/s41589-020-0504-2.
Article CAS PubMed Google Scholar
Liu X, Lai W, Li Y, Chen S, Liu B, Zhang N, Mo J, Lyu C, Zheng J, Du YR, et al. N(6)-methyladenine is incorporated into mammalian genome by DNA polymerase. Cell Res. 2021;31(1):94–7. https://doi.org/10.1038/s41422-020-0317-6.
Article CAS PubMed Google Scholar
Pfaffeneder T, Spada F, Wagner M, Brandmayr C, Laube SK, Eisen D, Truss M, Steinbacher J, Hackner B, Kotljarova O, et al. Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA. Nat Chem Biol. 2014;10(7):574–81. https://doi.org/10.1038/nchembio.1532.
Article CAS PubMed Google Scholar
Roberts SA, Gordenin DA. Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer. 2014;14(12):786–800. https://doi.org/10.1038/nrc3816.
Article CAS PubMed PubMed Central Google Scholar
Yuan B, Jiang Y, Wang Y, Wang Y. Efficient formation of the tandem thymine glycol/8-oxo-7,8-dihydroguanine lesion in isolated DNA and the mutagenic and cytotoxic properties of the tandem lesions in Escherichia coli cells. Chem Res Toxicol. 2010;23(1):11–9. https://doi.org/10.1021/tx9004264.
Article CAS PubMed PubMed Central Google Scholar
Dai Y, Yuan BF, Feng YQ. Quantification and mapping of DNA modifications. RSC Chem Biol. 2021;2(4):1096–114. https://doi.org/10.1039/d1cb00022e.
Article CAS PubMed PubMed Central Google Scholar
Hotchkiss RD. The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J Biol Chem. 1948Aug;175(1):315–32.
Article CAS PubMed Google Scholar
Dor Y, Cedar H. Principles of DNA methylation and their implications for biology and medicine. Lancet. 2018;392(10149):777–86. https://doi.org/10.1016/s0140-6736(18)31268-6.
Article CAS PubMed Google Scholar
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415–28. https://doi.org/10.1038/nrg816.
Article CAS PubMed Google Scholar
Heyn H, Esteller M. An adenine code for DNA: a second life for N6-methyladenine. Cell. 2015;161(4):710–3. https://doi.org/10.1016/j.cell.2015.04.021.
Article CAS PubMed Google Scholar
Luo GZ, He C. DNA N(6)-methyladenine in metazoans: functional epigenetic mark or bystander? Nat Struct Mol Biol. 2017;24(6):503–6. https://doi.org/10.1038/nsmb.3412.
Article CAS PubMed Google Scholar
Chen T, Li E. Establishment and maintenance of DNA methylation patterns in mammals. Curr Top Microbiol Immunol. 2006;301:179–201. https://doi.org/10.1007/3-540-31390-7_6.
Article CAS PubMed Google Scholar
Kim H, Kwon YM, Kim JS, Han J, Shim YM, Park J, Kim DH. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer. 2006;107(5):1042–9. https://doi.org/10.1002/cncr.22087.
Article CAS PubMed Google Scholar
Husni RE, Shiba-Ishii A, Iiyama S, Shiozawa T, Kim Y, Nakagawa T, Sato T, Kano J, Minami Y, Noguchi M. DNMT3a expression pattern and its prognostic value in lung adenocarcinoma. Lung Cancer. 2016;97:59–65. https://doi.org/10.1016/j.lungcan.2016.04.018.
Gao Q, Steine EJ, Barrasa MI, Hockemeyer D, Pawlak M, Fu D, Reddy S, Bell GW, Jaenisch R. Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc Natl Acad Sci U S A. 2011;108(44):18061–6. https://doi.org/10.1073/pnas.1114946108.
Article PubMed PubMed Central Google Scholar
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930–5. https://doi.org/10.1126/science.1170116.
Article CAS PubMed PubMed Central Google Scholar
Filipczak PT, Leng S, Tellez CS, Do KC, Grimes MJ, Thomas CL, Walton-Filipczak SR, Picchi MA, Belinsky SA. p53-suppressed oncogene TET1 prevents cellular aging in lung cancer. Cancer Res. 2019;79(8):1758–68. https://doi.org/10.1158/0008-5472.CAN-18-1234.
Article CAS PubMed PubMed Central Google Scholar
Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A. 2008;105(1):252–7. https://doi.org/10.1073/pnas.0710735105.
Kalari S, Jung M, Kernstine KH, Takahashi T, Pfeifer GP. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Oncogene. 2013;32(30):3559–68. https://doi.org/10.1038/onc.2012.362.
Article CAS PubMed Google Scholar
Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene. 2001;20(27):3528–32. https://doi.org/10.1038/sj.onc.1204455.
Article CAS PubMed Google Scholar
Yu Q, Guo Q, Chen L, Liu S. Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review. Drug Des Dev Ther. 2015;9:2171–8. https://doi.org/10.2147/dddt.s78537.
留言 (0)